Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3159361000168112 | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3159371000168118 | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | Is a | aripiprazole 400 mg + inert substance modified release injection, syringe | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | Is a | trade product unit of use | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | Is a | Abilify Maintena | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | has manufactured dose form | modified release injection | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | has unit of use | syringe | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | has intended active ingredient | inert substance | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | has intended active ingredient | aripiprazole | false | Inferred relationship | Some | 784835564 | |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | has Australian BoSS | aripiprazole | false | Inferred relationship | Some | 784835564 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe, dual chamber syringe | has TPUU | False | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | Inferred relationship | Some | |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | has TPUU | False | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set
FHIR